Lars L. Thomsen

2.0k total citations · 1 hit paper
35 papers, 1.5k citations indexed

About

Lars L. Thomsen is a scholar working on Hematology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Lars L. Thomsen has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Genetics and 8 papers in Psychiatry and Mental health. Recurrent topics in Lars L. Thomsen's work include Iron Metabolism and Disorders (15 papers), Hemoglobinopathies and Related Disorders (10 papers) and Erythropoietin and Anemia Treatment (9 papers). Lars L. Thomsen is often cited by papers focused on Iron Metabolism and Disorders (15 papers), Hemoglobinopathies and Related Disorders (10 papers) and Erythropoietin and Anemia Treatment (9 papers). Lars L. Thomsen collaborates with scholars based in Denmark, United States and Austria. Lars L. Thomsen's co-authors include Helle K. Iversen, Jes Olesen, Christina Kruuse, Pär I. Johansson, Michael Auerbach, Alice Rasmussen, Myles Wolf, Heinz Zoller, Jens Langhoff‐Roos and Richard J. Derman and has published in prestigious journals such as JAMA, Gut and Journal of Applied Physiology.

In The Last Decade

Lars L. Thomsen

35 papers receiving 1.5k citations

Hit Papers

Effects of Iron Isomaltos... 2020 2026 2022 2024 2020 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars L. Thomsen Denmark 21 621 529 360 306 243 35 1.5k
Nuray Duman Türkiye 26 437 0.7× 68 0.1× 159 0.4× 149 0.5× 56 0.2× 98 2.0k
Mohammad Saadatnia Iran 21 133 0.2× 288 0.5× 28 0.1× 173 0.6× 167 0.7× 123 1.4k
Enas A. Hamed Egypt 16 65 0.1× 303 0.6× 101 0.3× 113 0.4× 75 0.3× 38 879
Olympia Guiba-Tziampiri Greece 11 197 0.3× 48 0.1× 34 0.1× 123 0.4× 35 0.1× 23 818
Beata Ponikowska Poland 16 614 1.0× 27 0.1× 218 0.6× 114 0.4× 24 0.1× 47 1.3k
Peyamı Cınaz Türkiye 23 41 0.1× 103 0.2× 38 0.1× 249 0.8× 108 0.4× 91 1.5k
Gaetano Gorgone Italy 19 22 0.0× 193 0.4× 27 0.1× 100 0.3× 77 0.3× 40 877
Kiminori Kato Japan 22 39 0.1× 23 0.0× 65 0.2× 287 0.9× 56 0.2× 109 1.4k
Mogher Khamaisi Israel 20 28 0.0× 88 0.2× 40 0.1× 581 1.9× 65 0.3× 43 1.6k
Sebahat Özdem Türkiye 17 29 0.0× 33 0.1× 32 0.1× 105 0.3× 62 0.3× 74 746

Countries citing papers authored by Lars L. Thomsen

Since Specialization
Citations

This map shows the geographic impact of Lars L. Thomsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars L. Thomsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars L. Thomsen more than expected).

Fields of papers citing papers by Lars L. Thomsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars L. Thomsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars L. Thomsen. The network helps show where Lars L. Thomsen may publish in the future.

Co-authorship network of co-authors of Lars L. Thomsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars L. Thomsen. A scholar is included among the top collaborators of Lars L. Thomsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars L. Thomsen. Lars L. Thomsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Auerbach, Michael, Maureen M. Achebe, Lars L. Thomsen, & Richard J. Derman. (2022). Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery. Obesity Surgery. 32(3). 810–818. 7 indexed citations
3.
Wolf, Myles, Janet Rubin, Maureen Achebe, et al.. (2020). Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia. JAMA. 323(5). 432–432. 179 indexed citations breakdown →
4.
Wolf, Myles, Janet Rubin, Maureen Achebe, et al.. (2020). Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. 30 indexed citations
5.
Holm, Charlotte, Lars L. Thomsen, & Jens Langhoff‐Roos. (2018). Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage. The Journal of Maternal-Fetal & Neonatal Medicine. 32(17). 2797–2804. 22 indexed citations
6.
Holm, Charlotte, Lars L. Thomsen, A. Nørgaard, & Jens Langhoff‐Roos. (2017). Single‐dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial. Vox Sanguinis. 112(3). 219–228. 47 indexed citations
8.
Kalra, Philip A., et al.. (2015). A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrology Dialysis Transplantation. 31(4). 646–655. 74 indexed citations
9.
Thomsen, Lars L., et al.. (2014). [Spontaneous bilateral quadriceps tendon rupture in obese patient medicated with statin].. PubMed. 176(50). 2 indexed citations
10.
Thomsen, Lars L., et al.. (2014). Sympathetic block by metal clips may be a reversible operation. Interactive Cardiovascular and Thoracic Surgery. 19(6). 908–913. 12 indexed citations
11.
Kruuse, Christina, T Jacobsen, Lars L. Thomsen, et al.. (2000). Effects of the non‐selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects. European Journal of Neurology. 7(6). 629–638. 29 indexed citations
12.
Kruuse, Christina, T Jacobsen, L. H. Lassen, et al.. (2000). Dipyridamole Dilates Large Cerebral Arteries Concomitant to Headache Induction in Healthy Subjects. Journal of Cerebral Blood Flow & Metabolism. 20(9). 1372–1379. 41 indexed citations
13.
Eilenberg, Jørgen, Per Hyldebrink Damgaard, & Lars L. Thomsen. (1998). Pesticide research, 43: Activity of Bacillus thuringiensis strains against Pieris brassicae. 1 indexed citations
14.
Daugaard, D., Lars L. Thomsen, & Jes Olesen. (1998). No relation between cephalic venous dilatation and pain in migraine. Journal of Neurology Neurosurgery & Psychiatry. 65(2). 260–262. 15 indexed citations
15.
Thomsen, Lars L.. (1998). Treatment with Ciprofloxacin in Children with Typhoid Fever. Scandinavian Journal of Infectious Diseases. 30(4). 355–357. 11 indexed citations
16.
Lassen, L. H., Lars L. Thomsen, Christina Kruuse, Helle K. Iversen, & Jes Olesen. (1996). Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. European Journal of Clinical Pharmacology. 49(5). 335–339. 36 indexed citations
17.
Thomsen, Lars L., Helle K. Iversen, Claus Emmeluth, & Peter Bie. (1995). Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects. European Journal of Clinical Pharmacology. 48(2). 139–42. 5 indexed citations
18.
Thomsen, Lars L.. (1995). Arterial mechanisms in the pathophysiology of migraine headache—implications for modern therapy. European Journal of Neurology. 2(5). 403–415. 3 indexed citations
19.
Thomsen, Lars L., Christina Kruuse, Helle K. Iversen, & Jes Olesen. (1994). A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. European Journal of Neurology. 1(1). 73–80. 272 indexed citations
20.
Thomsen, Lars L., et al.. (1993). Arterial Supersensitivity to Nitric Oxide (Nitroglycerin) in Migraine Sufferers. Cephalalgia. 13(6). 395–399. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026